Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.

scientific article published in January 2008

Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1469-8749.2007.02009.X
P698PubMed publication ID18173626
P5875ResearchGate publication ID5675665

P50authorGiangennaro CoppolaQ38327706
Emilio FranzoniQ56977765
Elisabetta TozziQ57306927
Alberto VerrottiQ88336545
Federico VigevanoQ89961005
Paolo CuratoloQ90577566
Francesco ChiarelliQ114398527
Caterina CerminaraQ114398534
Paolo AloisiQ114398537
Paola IannettiQ114398541
P2093author name stringPasquale Parisi
Raffaella Cusmai
P2860cites workEndocrine and metabolic changes in epileptic patients receiving valproic acidQ36142002
A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonusQ43747015
Effect of sodium valproate on somatosensory evoked potentials in juvenile myoclonic epilepsyQ44093017
Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patientsQ44774918
P433issue1
P921main subject(S)-etiracetamQ417227
juvenile myoclonic epilepsyQ543517
teenagerQ1492760
myoclonic epilepsyQ11883686
P304page(s)29-32
P577publication date2008-01-01
P1433published inDevelopmental Medicine and Child NeurologyQ15716651
P1476titleLevetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents
P478volume50